Apremilast in the treatment of psoriatic arthritis: a perspective review.

about

Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis.Consensus on the management of patients with psoriatic arthritis in a dermatology setting.Tofacitinib in psoriatic arthritis.

P2860

Q39361316-FB46C423-5918-4313-8880-D7BA0443383F Q50002313-221563DF-8E18-44D0-8176-CA6896B02C0B Q54988148-B25C4B92-57D2-4857-AF94-AFC81599DA1F

P2860

Apremilast in the treatment of psoriatic arthritis: a perspective review.

Item

http://www.wikidata.org/entity/Q38932094

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Apremilast in the treatment of psoriatic arthritis: a perspective review.

@en

type

Item

label

Apremilast in the treatment of psoriatic arthritis: a perspective review.

@en

prefLabel

Apremilast in the treatment of psoriatic arthritis: a perspective review.

@en

P1476

Apremilast in the treatment of psoriatic arthritis: a perspective review.

@en

P2093

David Crosbie

http://www.w3.org/2001/XMLSchema#string

Michael Reed

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.

Disposition, metabolism and mass balance of [(14)C]apremilast following oral administration.

PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization

Prevalence of joint disease in patients with psoriasis: implications for therapy.

Psoriatic arthritis: epidemiology, clinical features, course, and outcome.

Localized effects of cAMP mediated by distinct routes of protein kinase A.

The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis

Cardiovascular risk in patients with psoriatic arthritis.

A randomized placebo-controlled trial of methotrexate in psoriatic arthritis

Metabolic disorders in patients with psoriasis and psoriatic arthritis.

P304

45-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1759720X16673786

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28255338

http://www.w3.org/2001/XMLSchema#string

P932

5315225

http://www.w3.org/2001/XMLSchema#string

Apremilast in the treatment of psoriatic arthritis: a perspective review.

about

P2860

P2860

Apremilast in the treatment of psoriatic arthritis: a perspective review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932